SCHEMBL17259159

SCHEMBL17259159

CCOC(=O)C[C@@H]1C[C@@H]1c1ccc(Cl)cc1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.47
HTR2C P28335 1/20 0.47
HTR2B P41595 1/20 0.47
ABCC1 P33527 1/20 0.46
HPGD P15428 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
HTT P42858 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.41
ALOX12 P18054 1/20 0.41
CNR1 P21554 1/20 0.41
OPRK1 P41145 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15798206 1.00 HTR2A (0.47) HTR2AHTR2CHTR2BABCC1HPGD
SCHEMBL2428840 0.87 MIF (0.47) HTR2AHTR2CHTR2BSMN1; SMN2KMT2A
SCHEMBL2437089 0.84 HTR2C (0.54) HTR2CHPGDSMN1; SMN2HTTMEN1
SCHEMBL15797925 0.84 HTR2C (0.54) HTR2CHPGDSMN1; SMN2HTTMEN1
SCHEMBL8324795 0.79 MIF (0.38) SMN1; SMN2CYP1A2ALDH1A1LMNA
SCHEMBL1709367 0.78 MEN1 (0.46) ABCC1HPGDSMN1; SMN2NPSR1MEN1
SCHEMBL8325401 0.77 FFAR1 (0.46) HTTMEN1KMT2AALDH1A1LMNA
SCHEMBL9031961 0.77 ABCC1 (0.46) HTR2AABCC1HPGDSMN1; SMN2NPSR1
SCHEMBL15213234 0.76 SLC9A1 (0.50) ABCC1HPGDSMN1; SMN2NPSR1HTT
SCHEMBL14622854 0.76 SLC9A1 (0.50) ABCC1HPGDSMN1; SMN2NPSR1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2931708-B1 CYCLOPROPYLBORONIC COMPOUNDS, METHOD FOR PREPARING SAME AND USE THEREOF DIVERCHIM (FR) 2017-05-10 EP disclosed
US-9527798-B2 Cyclopropylboronic compounds, preparation process thereof and use thereof DIVERCHIM (FR) 2016-12-27 US disclosed
US-20150329566-A1 CYCLOPROPYLBORONIC COMPOUNDS, METHOD FOR PREPARING SAME AND USE THEREOF DIVERCHIM (FR) 2015-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150329566-A1 CYCLOPROPYLBORONIC COMPOUNDS, METHOD FOR PREPARING SAME AND USE THEREOF HMBS, MMAB, FDPS HTR2A 4600/4885HTR2C 4775/4885HTR2B 2332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.